KLKb5 Inhibitors
KLKb5 inhibitors are a class of chemical compounds designed to target and modulate the activity of kallikrein-related peptidase 5 (KLK5), an enzyme primarily involved in proteolytic processes. KLK5 belongs to the family of serine proteases, which are known for their ability to cleave peptide bonds in proteins. KLK5 plays a significant role in skin desquamation, a process by which dead skin cells are shed, and its overactivation can lead to excessive degradation of structural proteins, potentially impacting cellular and extracellular interactions. KLKb5 inhibitors work by binding to the active site of KLK5, preventing it from catalyzing the breakdown of specific protein substrates. By doing so, these inhibitors help to maintain the integrity of the substrate proteins, ensuring that the enzymatic activity of KLK5 is kept under control in various biological systems.
These inhibitors are often small molecules or peptides that are specifically designed to achieve high selectivity for KLK5, distinguishing them from other members of the kallikrein family. The structural characteristics of these inhibitors typically include functional groups that interact with key amino acids in the KLK5 enzyme's active site. This selective binding helps to fine-tune the regulatory mechanisms of proteolysis in environments where KLK5 is active. Developing effective KLKb5 inhibitors requires an in-depth understanding of the enzyme's structure, including its substrate recognition sites, as well as insights into the dynamics of its catalytic mechanism. Research into KLKb5 inhibitors often involves biochemical assays to assess their binding affinity, specificity, and inhibitory potency, ensuring they effectively block KLK5 activity without unintended interactions with other serine proteases.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could directly reduce transcriptional activity of the KLKb5 gene by increasing histone acetylation, leading to a tightly packed chromatin structure that is less accessible to transcription machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could downregulate KLKb5 by incorporating into DNA and RNA, leading to the direct inhibition of DNA methyltransferases, resulting in DNA demethylation and repression of gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid might specifically decrease the expression of KLKb5 by targeting histone deacetylases, which would disrupt the removal of acetyl groups on histones, promoting a closed chromatin conformation that hinders gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
By binding to retinoic acid receptors that interact with the promoter region of KLKb5, retinoic acid could repress gene expression through the recruitment of co-repressor complexes to the DNA. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane could suppress the expression of the KLKb5 gene by activating antioxidant response pathways that may include the transcriptional downregulation of certain proteases as a secondary response to maintain cellular homeostasis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol might attenuate KLKb5 expression by interfering with DNA methyltransferases, which could lead to the hypomethylation of CpG islands in the promoter region, resulting in gene silencing. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein could specifically target the upstream signaling pathways that control the transcription of KLKb5, such as by inhibiting tyrosine kinases that trigger transcription factor activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has the potential to repress the transcription of KLKb5 by inhibiting the activation of NF-κB, a transcription factor that may directly bind to the promoter region of the gene and enhance its expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating SIRT1, a NAD-dependent deacetylase, resveratrol might lead to the deacetylation of histones at the KLKb5 gene locus, thereby suppressing its transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This chemical could downregulate KLKb5 by inhibiting the PI3K/Akt pathway, which can have a downstream effect on the expression of genes involved in cell survival and growth, including various proteases. | ||||||